FIELD: pharmaceutics.
SUBSTANCE: invention relates to novel N-phenylacetyl-substituted glyiprolines of the general formula: C6H5-CH2-C(O)-Gly-X-Pro-R, where X represents an L- or D-configuration, R = OCH3, or OC2H5, or NH2, or NHCH3. Novel compounds possess neuropsychotropic activity, including nootropic, neuroprotective, antihypoxic and anxiolytic activity and can be used as pharmaceutical agents; funds for the treatment of violations of cognitive functions, anxiety and neurodegenerative disorders.
EFFECT: can be used as pharmaceutical agents, agents for the treatment of cognitive impairment, anxiety disorders and neurodegenerative disorders.
8 cl, 1 dwg, 7 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
LINEAR SUBSTITUTED GLYPROLINE WITH ANTIDEPRESSANT AND ANALGESIC EFFECT | 2019 |
|
RU2756449C2 |
PYRROLO[1,2-A]PYRAZINE-CONTAINING LIGANDS OF THE 18 KDA TRANSLOCATOR PROTEIN WITH ANXIOLYTIC ACTIVITY | 2022 |
|
RU2812083C2 |
PHARMACEUTICAL COMPOSITION OF N-(6-PHENYLHEXANOYL)GLYCYL-L-TRYPTOPHAN AMIDE WITH FILM COATING AND THE METHOD OF ITS PRODUCTION | 2013 |
|
RU2663691C2 |
DERIVATIVES OF 4,6-DIMETHYL-2,3-DIHYDRO-1H-PYRAZOLO[4,3-c] PYRIDINE-3-ONES AND ETHERS 2,6-DIMETHYL-4-PHENYL-HYDRAZINE NICOTINIC ACIDS AS INTERMEDIATE PRODUCTS FOR THEIR SYNTHESIS, POSSESSING ANTIDEPRESSANT AND ANXIOLYTIC POTENCY | 2007 |
|
RU2394034C2 |
SMALL MOLECULES WITH NGF-LIKE ACTIVITY AND ANTIDIABETIC PROPERTIES | 2013 |
|
RU2613314C2 |
DERIVATIVES OF N-ACYLPROLYLDIPEPTIDES | 1993 |
|
RU2119496C1 |
DRUG FOR PREVENTION AND TREATMENT OF DIABETES | 2013 |
|
RU2597848C2 |
ACYLHYDRAZONE (2,3,4-TRIMETHOXY-N'-(8-METHYL-8-AZABICYCLO[3.2.1.]OCTANE-3-YLIDENE) BENZOHYDRAZIDE HYDROCHLORIDE), HAVING ANTIMIGRAINE AND ANXIOLYTIC ACTIVITY | 2016 |
|
RU2699658C2 |
PHARMACEUTICAL COMPOSITION CONTAINING PHYSIOLOGICALLY ACTIVE HEPTAPEPTIDES, HAVING ANTISPASMODIC, ANXIOLYTIC, CENTRAL ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY, AS WELL AS ANTI-ALCOHOL ACTIVITY | 2012 |
|
RU2506269C1 |
PHARMACEUTICAL COMPOSITION BASED ON N-BENZYL-N-METHYL-1-PHENYLPYRROLO [1,2-A] PYRAZINE-3-CARBOXAMIDE | 2017 |
|
RU2689396C2 |
Authors
Dates
2018-03-06—Published
2016-01-12—Filed